Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Parkinson's Disease
Clinical trial NCT02954978 · COMPLETED
Trial details
- NCT number
- NCT02954978
- Sponsor
- Georgetown University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2020-05-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.